Managing Healthcare Reform: Winning Strategies for Engaging the Government Ecosystem That Shapes...
-
Upload
best-practices-llc -
Category
News & Politics
-
view
1.254 -
download
0
description
Transcript of Managing Healthcare Reform: Winning Strategies for Engaging the Government Ecosystem That Shapes...
BEST PRACTICES,
®
LLC
Best Practices, LLC Strategic Benchmarking Research
Managing Healthcare Reform: Winning Strategies for Engaging the Government
Ecosystem That Shapes Healthcare Policy
BEST PRACTICES,
®
LLC
Table of Contents
I. Executive Summary pp. 4-17
Research Overview pp. 5
Universe of Learning pp. 6
Overview of Data and Issue pp.7-10
Key Findings pp. 11-17
II. Universe of Learning: Key Demographics of Participating Companies pp. 18-22
III. Align Structures, Resources & Groups To Manage The Healthcare “Ecosystem”
pp.23-40
IV. Intelligence Gathering: “The Capture” pp.41-55
Being well-positioned to capture vital information From Within The
Washington Ecosystem
V. Intelligence Dissemination: “The Routing” pp.56-64
How to share intelligence & insights with key executives and functions
VI. Intelligence Translation: “The Interpretation” pp.65-72
Determining what Information Coming from the Government Ecosystem
means for brands, functions & business lines
BEST PRACTICES,
®
LLC
Table of Contents
IX. Intelligence Implementation: “The Response” pp.73-90
Converting Government Ecosystem intelligence into strategies, plans, tactics
and messages
X. Government Affairs pp.91-97
How Companies Place Their Government Affairs Resources To Monitor &
Manage Public-sector Healthcare Reform
XI. Public Policy Benchmarks pp.98-109
How Companies Place Their Policy Resources To Monitor & Manage Public-
sector Healthcare Reform
XII. Government Affairs & Public Policy Staffing Benchmarks pp. 110-117
What Staffing Investments Are Companies Making To Manage the
Government Ecosystem?
XIII.Future Trends & Lessons Learned pp. 118-121
XIV.Appendix pp. 122-125
BEST PRACTICES,
®
LLC
Objectives:
Close gaps in how pharma engages CMS and other groups that influence federal healthcare policy, guidelines and reimbursement.
Close gaps in how Policy, Government Affairs and Marketing collaborate to manage public sector healthcare changes to the benefit of product portfolio.
Identify best practices in organizational form, focus, and function to best position organizations for the future where the government payer is increasingly influential.
Business Issue & Objectives
The influence of CMS on healthcare policy and reimbursement is increasing as the US population ages and
healthcare reform unfolds. Consequently, the importance of understanding, translating, and engaging with
CMS and other influential healthcare groups continues to grow.
Harvesting Insights & Analysis: Expert Sources: Study Objective:
23 Biopharma Companies
participated
6 Companies participated in
deep-dive interviews
Expert
Interviews
Industry
Benchmark INF
OR
M
Formulate a Strategic Approach for Optimizing
engagement with CMS and the ecosystem of agencies
and groups that shape U.S. healthcare guidelines and reimbursement policy.
4
Copyright © Best Practices, LLC
BEST PRACTICES,
®
LLC
5
Copyright © Best Practices, LLC
23 Healthcare Companies Provide Universe of Learning
This study engaged executives from 23 leading healthcare companies. Segmentation analysis was key to
examining trends and effective practices. Eight participants represent both the Large Pharma Segment
(LPS) and Mid-Cap Segment (MPS). The Emerging Segment consists of seven companies. In addition,
deep-dive interviews were conducted with six participating companies to gather additional insights.
(n = 8)
Large Pharma Segment: Mid-Cap Segment:
(n = 8) (n = 7)
Emerging Pharma Segment:
BEST PRACTICES,
®
LLC
Framework For Managing The Government Ecosystem
Managing The
Government
Healthcare
“Ecosystem”
3. Intelligence Dissemination:
(How To Share Intel & Insights With Key Execs & Functions)
4. Intelligence Translation: (Determining
What It Means for Brands, Functions & Business Lines)
5. Intelligence Implementation:
(Converting Intel into Strategies, Plans, Tactics & Messages)
2. Intelligence Gathering:
(How To Be Well-positioned To Capture Vital Information)
6. Resource Benchmarks:
(What Cross-Functional Resources Are Required To
Manage The Ecosystem)
1. Align Resources & Groups To Manage
The Healthcare Eco-system
Field insights and observations emerged across a full spectrum of management factors – including strategy, structure, staffing, process excellence, communication and cross-functional coordination. The analysis, benchmark review and insights have been organized into the following framework that represents key areas for engaging the government ecosystem.
6
Copyright © Best Practices, LLC
BEST PRACTICES,
®
LLC
Pharma Coverage of the Federal “Ecosystem” Is Uneven –
With Largest Competitors Pursuing Most Strategic Approach
7
Copyright © Best Practices, LLC
Q. Coverage of Federal Healthcare Groups: Which groups do you monitor as part of covering federal
government? (Percentage of Companies Covering Federal Agency)
The patchwork of federal agencies and groups that shape healthcare policy is like an ecosystem of influence in Washington, DC. Field research reveals that there is significant variation in terms of how well different companies cover the various groups influencing public healthcare policy. The very largest biopharma companies invest resources to cover all these agencies and influence groups.
FDA,
78%
AHRQ,
78%
CMS,
94%
IoM,
44%
NIH,
56%
IRS
<15%
VA
<15%
HHS
<15%
1) Many Cover
FDA During
Product
Introduction &
CMS Regarding
Reimbursement
2) However, only
the largest
companies Cover
Other Agencies
That Influence
Healthcare Policy,
Tax or Therapeutic
Issues.
(n=18)
ONC
<15%
HRSA
<15%
PCORI
79%
CDC
39%
BEST PRACTICES,
®
LLC
The global revenues in 2011 for research participants ranged from $200 million to $67 billion – illustrating how the study attracted organizations of all sizes. To better reflect responses from like-sized companies, data is presented in three Segments when appropriate: Total Benchmark Class, Large Pharma, and Mid-Cap pharma.
Median Global Revenues for Participants Is $11.5 Billion
8
Copyright © Best Practices, LLC
Q. Revenues: Estimate total sales revenues for your organization for the last completed fiscal year
(2011).
Global Revenues:
Total Benchmark
Class
Max $67,400,000,000
75th Percentile $32,400,000,000
Mean $18,304,300,000
Median $11,500,000,000
25th Percentile $3,775,000,000
Min $200,000,000
(n=20)
Large Pharma Mid-Cap Emerging
Pharma
$67,400,000,000 $17,000,000,000 $6,000,000,000
$43,886,750,000 $11,500,000,000 $872,000,000
$36,905,875,000 $8,909,000,000 $1,695,200,000
$33,800,000,000 $11,000,000,000 $754,000,000
$29,250,000,000 $4,131,500,000 $650,000,000
$16,700,000,000 $3,100,000,000 $200,000,000
(n=8) (n=7) (n=5)
BEST PRACTICES,
®
LLC
Companies Monitor Most Major Agencies & Influencing Groups
9
Copyright © Best Practices, LLC
Q. Coverage of Federal Healthcare Groups: Which groups do
you monitor as part of covering the federal government?
Most companies monitor major federal healthcare agencies and influencing groups. The very largest companies also extend coverage to various groups – like HHS, VA, IRS and ONC – that smaller and mid-cap companies seldom engage. Scope of coverage reflect maturity.
(n=18)
Total Federal Agencies & Groups Covered
39%
44%
56%
78%
78%
94%
22%
0%None
Other
CDC
IoM
NIH
FDA
AHRQ
CMS
Other:
• HHS; ONC; VA, HRSA, IRS;
Various other agencies like
PCORI that resulted from
ACA
Q. Coverage of CMS Influencing Groups: Which groups do
you monitor as part of covering CMS?
26%
32%
47%
58%
58%
68%
79%
11%
5%Other
None
Quality Alliance Steering Committee
Regional CMS Offices
MACPAC
NQF
NCQA
MedPAC
PCORI
Total Influencing Groups Covered
(n=19) Other:
• MACs
BEST PRACTICES,
®
LLC
Many Mid-caps Fail to Forge Formal Strategies for Engaging the Federal
Government. Big Pharma Is Far More Strategic
10
Copyright © Best Practices, LLC
Q. Strategic Engagement Strategy for Federal Government: Please note whether your organization
has an engagement strategy (detailed plans with groups assigned roles, responsibilities and tactics)
for working with each of these Federal Government groups or healthcare agencies
With the exception of the FDA and CMS, most companies have yet to devise formal strategies for engaging and working with a wide range of federal agencies that affect healthcare policy. The Large Pharma Segment is more than twice as likely to have formal strategies to engage the Federal Government across multiple agencies.
5%
9%
14%
24%
19%
33%
57%
50%
19%
36%
48%
43%
52%
38%
29%
40%
76%
38%
33%
29%
29%
14%
10%
55%
Federal Drug Administration (FDA)
Center for Medicare and Medicaid Services
Veteran Affairs
National Institutes of Health
Dept. of Health & Human Services (HHS) At
Large (overseeing CMS, FDA, NIH, etc.)
Agency for Healthcare Research & Quality
(AHRQ)
Institute of Medicine (IOM) of National
Academy of Sciences
Center for Disease Control (CDC)
Total Benchmark Class: Informal Strategy Formal Strategy No Strategy n =
21
22
21
21
21
21
21
20
Formal Strategy:
100% 29%
88% 43%
43% 43%
43% 0%
43% 14%
71% 0%
14% 0%
29% 0%
LPS: MCS:
(n=8) (n=7)
BEST PRACTICES,
®
LLC
Merck Utilizes Influencing Groups to Promote Health, Business
11
Copyright © Best Practices, LLC
Few companies are as adroit as Merck when it comes to utilizing influencing groups to improve the positioning of its products. In the recent past there was Januvia and Gardasil, and most recently was Victrelis, the company’s new first-in-class treatment for chronic hepatitis C. Through its support of both the Viral Hepatitis Action Coalition and the CDC Foundation, Merck helped influence a more favorable environment for Victrelis. All of these products are important therapies that together could save tens of thousands of lives and billions of dollars in healthcare spending.
Merck launches public
education/support programs for
chronic hepatitis C (HCV) and
announces funding to CDC-
affiliated VHAC (Viral Hepatitis
Action Coalition)
The FDA approves
Victrelis, a 1st in class
HCV treatment costing
$26k to $48k. CDC launches National Hepatitis Test Day
and, in a major policy shift, proposes all 75
million Baby Boomers get tested for HCV
The CDC estimates 800,000
cases will be spotted early
through testing. Nearly 10,000
HCV patients die annually.
May 9, 2011
May 18, 2012 May 13, 2011
800,000 patients x $26k =
$20B Drug for Merck
BEST PRACTICES,
®
LLC
More than 50% of Companies Are Currently Engaging ACOs
Yes
55%
No
45%
12
Copyright © Best Practices, LLC
Yes
62%No
38%
Yes
57%
No
43%
Q. U.S. State-Level Relationship Engagement Strategy: Does your organization have an engagement
strategy regarding state-level relationships revolving around Accountable Care Organizations?
Nearly two-thirds of the Large Pharma Segment have begun devising engagement strategies for Account Care Organizations. More than half of mid-cap companies have begun such work. Interestingly, mid-cap companies seem to have focused more closely on the ACO’s than state Medicaid or Health Insurance issues.
(n=20)
Total Benchmark Class: Large Pharma:
Mid-Cap Segment:
(n=8)
(n=7)
Accountable Care Organizations:
BEST PRACTICES,
®
LLC
The Connection Between State Health Exchanges (HIX), Essential Health Benefits (EHB) and Benchmark Plans
13
Copyright © Best Practices, LLC
What is a State Health Insurance Exchange?
State Health Insurance Exchange (HIX)
A set of standardized insurance plans regulated by states and offered by
private insurers.
Essential Health Benefits (EHB)
The EHB of the plans in the exchange will not
differ significantly and must be equal to “typical
employer plan.”
Benchmark Plan
Serves as a reference plan, reflecting the
scope of the services and any limits. Feds
suggest four benchmark plan types for 2014 and
2015.
• Feds say EHB will be defined by a
benchmark plan elected by each
state. States told to select a
benchmark plan by 4th quarter
2012.
• Plans in a State Health Exchange (HIX) must cover 10 Essential Health Benefits (EHB) - one of which is prescription drugs.
• All exchanges must be
fully certified and
operational by January 1,
2014 – if states don’t set
up, the feds will.
The Affordable Care Act is giving rise to the creation of state health exchanges – in short a state-approved list of health plans for consumers and employers to choose from. Individuals will choose from plans that will fall into four categories, from lowest premium to highest premium: bronze, silver, gold, and platinum. Metal levels relate to cost-sharing features (e.g. bronze covers 60% of cost, silver = 70%, gold=80%, platinum=90%).
BEST PRACTICES,
®
LLC
Most Policy Staff Located Where Legislative Action Is: DC
14
Copyright © Best Practices, LLC
Q. U.S. Public Policy Staff Mix: Estimate the percentage of your Policy-focused staff in each job
location below. (The total of your percentages should equal 100% of your Policy staff.
While organizations are divided about where Public Policy’s primary location should be, this slide shows that, on average, participants have a majority of their policy staff located in Washington, DC. Headquarters serves as the second largest location.
Brand or BU, 2%
Fractionally
dedicated, 6%
Headquarters
40%
Washington, DC
52%
Max 100%
75th Percentile 75%
Mean 53%
Median 53%
25th Percentile 26%
Min 0%
Located with Brand or BU:
Max 30%
75th Percentile 0%
Mean 2%
Median 0%
25th Percentile 0%
Min 0%
Max 50%
75th Percentile 0%
Mean 6%
Median 0%
25th Percentile 0%
Min 0%
Fractionally Dedicated:
Located in Washington, DC:
Max 100%
75th Percentile 58%
Mean 40%
Median 38%
25th Percentile 21%
Min 0%
Located at Headquarters: Total Benchmark Class:
(n=18)
BEST PRACTICES,
®
LLC
15
Copyright © Best Practices, LLC
Best Practices, LLC is a research and consulting firm that conducts work
based on the simple yet profound principle that organizations can chart a
course to superior economic performance by studying the best business
practices, operating tactics and winning strategies of world-class
companies.
Best Practices, LLC
6350 Quadrangle Drive, Suite 200, Chapel Hill, NC 27517
919-403-0251
www.best-in-class.com
About Best Practices, LLC